In a plenary session at the 2026 European Hematology Association (EHA) annual meeting in Stockholm, Johnson & Johnson brought ...

An independent research firm is reviewing data on Amgen’s Tavneos as the company prepares for a hearing later this month with ...

The accelerated approval for Jazz Pharmaceuticals’ small cell lung cancer (SCLC) drug Zepzelca may once again be in jeopardy.

Audio is becoming an increasingly important area of focus in pharma marketing, and now four big drugmakers have become ...

While patients in Novo trials don't need to take any action, the company recommends patients "remain vigilant and report to ...

Staring down a $6 billion patent cliff for its prostate cancer drug Xtandi, Astellas aims to counter the inevitable revenue ...

Last year, Johnson & Johnson arrived late to the party with Imaavy as the third FcRn blocker approved since 2021 to treat ...

Madrigal Pharmaceuticals has installed a 20-foot-tall, 41-foot-wide inflatable liver in a Philadelphia park to mark Global ...

With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for ...

Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes ...

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the ...

Three short films created through an Eli Lilly-sponsored initiative are premiering at the Tribeca Festival, furthering the ...